The Office of the Inspector General looked at how testosterone replacement therapy was being prescribed by the Veterans' Administration and found that they did not follow the Endocrine Society's guidelines. A summary of their findings is online.
The OIG found that VA providers generally did not follow Endocrine Society Clinical Practice Guidelines and current VA criteria for use when initiating patients with testosterone replacement therapy or following up with patients within 3–6 months after therapy initiation.